Allied Corp has released its first GMP (Good Manufacturing Practices) certified medical cannabis batch into the European market. Allied's Colombian-grown cannabis flower is now available for sale to patients in Switzerland by PhytoXtract SA ("PhytoXtract"), Allied's local GMP manufacturing partner, as a magistral medicinal product, a personalized medicine prepared based on doctors' prescriptions.
This follows a shipment of THC-based cannabis flower to PhytoXtract SA as announced in April of this year. The Allied flower has since been processed, manufactured, and released as GMP product into the market. This was following independent Swiss laboratory testing that confirmed its compliance with European Pharmacopeia standards.
Michael Moses, Chief Business Development Officer said: "This first GMP product release into Switzerland is significant. We look forward to deepening our partnership with PhytoXtract and reaching more patients across Europe."
For more information:
Allied Corp
allied.health